Donor transmitted andde novocancer after liver transplantation
Open Access
- 1 January 2014
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (20), 6170-9
- https://doi.org/10.3748/wjg.v20.i20.6170
Abstract
Cancers in solid organ recipients may be classified as donor transmitted, donor derived, de novo or recurrent. The risk of donor-transmitted cancer is very low and can be reduced by careful screening of the donor but cannot be abolished and, in the United Kingdom series is less than 0.03%. For donors with a known history of cancer, the risks will depend on the nature of the cancer, the interventions given and the interval between diagnosis and organ donation. The risks of cancer transmission must be balanced against the risks of death awaiting a new graft and strict adherence to current guidelines may result increased patient death. Organs from selected patients, even with high-grade central nervous system (CNS) malignancy and after a shunt, can, in some circumstances, be considered. Of potential donors with non-CNS cancers, whether organs may be safely used again depends on the nature of the cancer, the treatment and interval. Data are scarce about the most appropriate treatment when donor transmitted cancer is diagnosed: sometimes substitution of agents and reduction of the immunosuppressive load may be adequate and the impact of graft removal should be considered but not always indicated. Liver allograft recipients are at increased risk of some de novo cancers, especially those grafted for alcohol-related liver disease and hepatitis C virus infection. The risk of lymphoproliferative disease and cancers of the skin, upper airway and bowel are increased but not breast. Recipients should be advised to avoid risk behavior and monitored appropriately.Keywords
This publication has 73 references indexed in Scilit:
- Donor-Transmitted Malignancy in a Liver Transplant Recipient: A Case Report and Review of LiteratureDigestive Diseases and Sciences, 2012
- Spectrum of Cancer Risk Among US Solid Organ Transplant RecipientsJAMA, 2011
- Donor-Transmitted Malignancies in Organ Transplantation: Assessment of Clinical RiskAmerican Journal of Transplantation, 2011
- Urothelial carcinoma transmission via kidney transplantationNephrology Dialysis Transplantation, 2009
- Donor transmission of malignant melanoma to a liver graft recipient: case report and literature reviewClinical Transplantation, 2009
- Donor-transmitted malignancy confirmed by quantitative fluorescence polymerase chain reaction genotype analysis: A rare indication for liver retransplantationLiver Transplantation, 2008
- Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantationLiver Transplantation, 2002
- Transmission of cancer from organ donors.1997
- ACCIDENTAL TRANSPLANTATION OF MALIGNANT TUMOR FROM A DONOR TO MULTIPLE RECIPIENTSTransplantation, 1987
- TRANSPLANTED CARCINOMA IN AN IMMUNOSUPPRESSED PATIENTTransplantation, 1970